Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Qiong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5936-7059; OpenAlex author ID A5054174618. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Nano-Econazole Enhanced PD-L1 Checkpoint Blockade for Synergistic Antitumor Immunotherapy against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/smll.202207201↗
  2. Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Co-author DOI 10.1158/1535-7163.mct-17-1142↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Canhua Huang · 1 shared paper, 2023 · strength 0.16
  2. Patrick M. Grierson · 1 shared paper, 2018 · strength 0.08
  3. Hongmei Jiang · 1 shared paper, 2018 · strength 0.08
  4. Daoxiang Zhang · 1 shared paper, 2018 · strength 0.08
  5. Paarth B. Dodhiawala · 1 shared paper, 2018 · strength 0.08
  6. Kian‐Huat Lim · 1 shared paper, 2018 · strength 0.08
  7. Andrea Wang‐Gillam · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.